Open access · CC-BY
via OpenAlex
Models of α-synuclein aggregation in Parkinson’s disease
Rosa M. Giráldez‐Pérez, Mónica Antolín‐Vallespín, Marı́a-Dolores Muñoz, Amelia Sánchez‐Capelo
Acta Neuropathologica Communications · 2014 · ▲ 133 citations
Abstract
Parkinson's disease (PD) is not only characterized by motor disturbances but also, by cognitive, sensory, psychiatric and autonomic dysfunction. It has been proposed that some of these symptoms might be related to the widespread pathology of α-synuclein (α-syn) aggregation in different nuclei of the central and peripheral nervous system. However, the pathogenic formation of α-syn aggregates in different brain areas of PD patients is poorly understood. Most experimental models of PD are valuable to assess specific aspects of its pathogenesis, such as toxin-induced dopaminergic neurodegeneration. However, new models are required that reflect the widespread and progressive formation of α-syn aggregates in different brain areas. Such α-syn aggregation is induced in only a few animal models, for example perikaryon inclusions are found in rats administered rotenone, aggregates with a neuritic morphology develop in mice overexpressing either mutated or wild-type α-syn, and in Smad3 deficient mice, aggregates form extensively in the perikaryon and neurites of specific brain nuclei. In this review we focus on α-syn aggregation in the human disorder, its genetics and the availability of experimental models. Indeed, evidences show that dopamine (DA) metabolism may be related to α-syn and its conformational plasticity, suggesting an interesting link between the two pathological hallmarks of PD: dopaminergic neurodegeneration and Lewy body (LB) formation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40478-014-0176-9
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Giráldez‐Pérez, R.M., Antolín‐Vallespín, M., Muñoz, M., & Sánchez‐Capelo, A. (2014). Models of α-synuclein aggregation in Parkinson’s disease. <em>Acta Neuropathologica Communications</em>. https://doi.org/10.1186/s40478-014-0176-9
Vancouver
Giráldez‐Pérez RM, Antolín‐Vallespín M, Muñoz M, Sánchez‐Capelo A. Models of α-synuclein aggregation in Parkinson’s disease. Acta Neuropathologica Communications. 2014. doi:10.1186/s40478-014-0176-9.
BibTeX
@article{rosa2014Models,
title = {Models of α-synuclein aggregation in Parkinson’s disease},
author = {Rosa M. Giráldez‐Pérez and Mónica Antolín‐Vallespín and Marı́a-Dolores Muñoz and Amelia Sánchez‐Capelo},
journal = {Acta Neuropathologica Communications},
year = {2014},
doi = {10.1186/s40478-014-0176-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain and Behavior 2022
Open access · CC-BY
Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
Translational Neurodegeneration 2019
Open access · CC-BY
Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
Biochemical and Biophysical Research Communications 2025
Open access · CC-BY
Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency
Journal of Neurochemistry 2025
Open access · CC-BY
Clearance Pathways for α‐Synuclein in Parkinson's Disease
Journal of Neurochemistry 2016
Open access · CC-BY
The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
Frontiers in Neuroscience 2018
Open access · CC-BY